Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) FCF Margin: 2019-2024

Historic FCF Margin for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to 2.42%.

  • Eton Pharmaceuticals' FCF Margin rose 2369.00% to 52.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 38.33%, marking a year-over-year increase of 3465.00%. This contributed to the annual value of 2.42% for FY2024, which is 1912.00% down from last year.
  • As of FY2024, Eton Pharmaceuticals' FCF Margin stood at 2.42%, which was down 88.78% from 21.54% recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' FCF Margin registered a high of 22.51% during FY2022, and its lowest value of -57,425.64% during FY2020.
  • Its 3-year average for FCF Margin is 15.49%, with a median of 21.54% in 2023.
  • Its FCF Margin has fluctuated over the past 5 years, first crashed by 5,543,169bps in 2020, then soared by 5,740,398bps in 2021.
  • Eton Pharmaceuticals' FCF Margin (Yearly) stood at -57,425.64% in 2020, then surged by 5,740,398bps to -21.67% in 2021, then surged by 4,417bps to 22.51% in 2022, then slumped by 97bps to 21.54% in 2023, then slumped by 1,912bps to 2.42% in 2024.